VRTX · Vertex Pharmaceuticals Incorporated
477.36
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$120.07B
PE
0.00
EV/EBITDA
21.4
DIV Yield
0%
Payout Ratio
0%
MQV Rating
3Neutral
As at 24/07/2026 04:00:00 PM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- HALO 200
- HALO 500
- HALO All
- HALO Balance Sheet
- Hammer Bullish
- Hammer Bullish (Realtime)
Key Fundamentals
EPS 3 yr Growth
-122.90%
EBITDA Margin
41.60%
Operating Cashflow
-$493m
Free Cash Flow Return
-2.70%
ROIC
-2.90%
Interest Coverage
149.20
Quick Ratio
2.40
Performance
52 weeks range
Low 362.5 - 533.67
Trade Value (12mth)
US$169,446,544.00
1 week
-2.66%
1 month
-0.44%
YTD
4.64%
1 year
0.17%
All time high
533.67
Additional Data
Shares Outstanding (Fully Diluted)
260m
HALO Sector
Healthcare
Next Company Report Date
09-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Neutral
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Strong
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Very Strong
Valuation
News & Announcements
| Date | Event |
07 July 26EDG | |
07 July 26EDG | |
14 May 26EDG | |
14 May 26EDG | |
14 May 26EDG |